Huntington’s disease, a relentlessly progressive neurodegenerative disorder, is notorious for its gradual erosion of motor control, cognitive function, and emotional regulation. The illness stems from the accumulation of a mutant huntingtin protein that exerts toxic effects on neurons, ultimately leading to their demise. Although it has long been recognized that this pathogenic protein disseminates from one neuron to another, the precise mechanisms driving this intercellular spread have remained largely enigmatic. A groundbreaking study conducted by researchers at Florida Atlantic University in collaboration with international partners now illuminates this mystery, uncovering a novel cellular conduit facilitating the direct transmission of harmful proteins.
The investigative team has identified microscopic intercellular channels known as tunneling nanotubes (TNTs), which serve as physical bridges connecting neighboring neurons. Unlike traditional signaling modalities that rely on diffusible chemical messengers, TNTs enable the hand-delivery of proteins and other cellular cargoes, allowing cells to share molecular contents with their neighbors in a precise and regulated manner. While such exchanges can sometimes be beneficial during cellular stress responses, in Huntington’s disease, TNTs become hijacked pathways through which the toxic mutant huntingtin protein spreads, propagating neurodegeneration.
Central to this discovery is the elucidation of how TNTs form and function in diseased neurons. Researchers revealed that the small GTPase-like protein Rhes, already implicated in Huntington’s pathology, forms a critical functional complex with SLC4A7, a bicarbonate transporter traditionally recognized for its role in maintaining intracellular pH homeostasis. This unexpected partnership orchestrates the emergence of tunneling nanotubes, effectively creating cellular highways along which the mutant huntingtin protein travels from one neuron to another.
Through a series of advanced biochemical and imaging techniques, the team demonstrated that the Rhes–SLC4A7 complex localizes at the neuronal plasma membrane, where it initiates intracellular signaling cascades promoting the polymerization of actin filaments—a cytoskeletal rearrangement fundamental to TNT extension. Genetic silencing or pharmacological inhibition of SLC4A7 disrupted TNT formation, significantly curtailing the intercellular trafficking of the mutant huntingtin protein. This mechanistic insight suggests a potential therapeutic target for halting disease progression by interrupting the physical routes of pathogenic spread.
The implications of this research extend into in vivo models, where genetically modified mice deficient in SLC4A7 presented markedly diminished mutant huntingtin propagation within the striatum. The striatum, a brain region critically affected in Huntington’s disease, revealed a pronounced decrease in neurotoxic transmission, reinforcing the vital role this newly characterized pathway plays in disease dynamics. Inhibiting nanotube-mediated protein transfer may therefore provide a tangible strategy to stem the neuronal damage that underlies clinical symptoms.
Beyond Huntington’s disease, the study carries profound significance for a spectrum of neurodegenerative disorders. Tunneling nanotubes are increasingly recognized as conduits in the intercellular passage of pathological proteins such as tau and alpha-synuclein, hallmark agents in Alzheimer’s and Parkinson’s diseases, respectively. Furthermore, cancer cells leverage similar nanotube structures to exchange survival signals and resist chemotherapeutic agents. By elucidating the Rhes–SLC4A7 axis as a master regulator of TNT biogenesis, this work unveils a molecular linchpin that may be exploited to broadly impede pathological intercellular communication across diverse ailments.
The discovery of SLC4A7’s moonlighting role in TNT formation challenges the traditional view of this protein solely as a pH regulator. It appears that perturbations in intracellular acid-base balance, potentially modulated through SLC4A7 activity, could be intricately tied to cytoskeletal dynamics and membrane remodeling necessary for nanotube extension. This integrative understanding of cellular physiology opens new avenues for drug development aimed at modulating these fundamental processes without compromising essential cell functions.
Senior author Dr. Srinivasa Subramaniam emphasized that these findings revolutionize the conceptual framework of neurodegenerative disease progression. By revealing the machinery that physically mobilizes toxic proteins between neurons, therapeutic strategies can now shift toward targeting the structural origins of pathology transmission, rather than merely attempting to degrade or neutralize the toxic proteins post hoc. Such approaches promise to delay or prevent the cascade of neuronal loss that underpins disability.
Complementing this perspective, Dr. Randy Blakely, director of FAU’s Stiles-Nicholson Brain Institute, highlighted the beacon of hope this research kindles for neurotherapeutics. He noted that targeting cellular “communication tunnels” represents a wholly novel and promising treatment modality that could extend far beyond Huntington’s to encompass other debilitating diseases. This mechanistic insight fortifies the foundational knowledge required to pioneer next-generation medicines capable of halting or even reversing neuropathological spread.
The technical rigor of the study was bolstered by multidisciplinary collaboration, incorporating computational simulations to map protein-protein interactions and dynamic imaging to visualize nanotube formation in real time. Such integrative methodologies underscored the power of combining molecular biology and biophysical analyses to decode complex cellular phenomena. The approach exemplifies how modern science transcends traditional boundaries to yield transformative biomedical discoveries.
As investigations proceed, researchers aim to elucidate the precise biochemical signals downstream of the Rhes–SLC4A7 interaction that drive cytoskeletal rearrangements, and to identify small-molecule inhibitors or biological agents capable of selectively disrupting TNT formation in vulnerable neurons. These endeavors hold the promise of translating foundational research into tangible clinical interventions that can mitigate suffering and improve quality of life for individuals grappling with Huntington’s and related illnesses.
Ultimately, this seminal research reshapes our understanding of neuronal communication in health and disease, revealing that the spread of toxic proteins is an active, mediated process reliant on specialized cellular structures rather than passive diffusion alone. By unmasking the molecular architecture underlying this intercellular highway, scientists have taken a monumental step towards dismantling the pathological networks that propagate neurodegeneration, ushering in a new frontier of hope for millions worldwide.
Subject of Research: Animals
Article Title: Membrane-Associated Rhes–Slc4a7 Complex Orchestrates Tunneling Nanotube Formation and Mutant Huntingtin Spread
News Publication Date: 20-Mar-2026
Image Credits: Emaad Mirza, Florida Atlantic University
Keywords: Huntington’s disease, neurodegenerative diseases, neurons, molecular mapping, nanotubes, protein functions, protein activity, disease progression, disease intervention, signaling pathways, cells, brain, disease control
Tags: cellular stress response nanotubesFAU Huntington’s disease researchHuntington’s disease neurodegenerationintercellular protein spread mechanismsmicroscopic neuronal communication channelsmutant huntingtin protein transmissionneurodegeneration progression inhibitionneurodegenerative disease cellular pathwaysneuron-to-neuron protein transfernovel cellular conduits in neurodegenerative diseasestargeted Huntington’s disease therapiestunneling nanotubes in neurons
